25 XP   0   0   10

Yichang Hec Changjiang Pharm
Buy, Hold or Sell?

Let's analyse Yichang Hec Changjiang Pharm together

PenkeI guess you are interested in Yichang Hec Changjiang Pharm. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Yichang Hec Changjiang Pharm. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Yichang Hec Changjiang Pharm

I send you an email if I find something interesting about Yichang Hec Changjiang Pharm.

Quick analysis of Yichang Hec Changjiang Pharm (30 sec.)










What can you expect buying and holding a share of Yichang Hec Changjiang Pharm? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
80.0%

What is your share worth?

Current worth
HK$7.23
Expected worth in 1 year
HK$7.61
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
HK$0.38
Return On Investment
2.9%

For what price can you sell your share?

Current Price per Share
HK$12.78
Expected price per share
HK$10.06 - HK$
How sure are you?
50%

1. Valuation of Yichang Hec Changjiang Pharm (5 min.)




Live pricePrice per Share (EOD)

HK$12.78

Intrinsic Value Per Share

HK$1.98 - HK$10.72

Total Value Per Share

HK$9.22 - HK$17.95

2. Growth of Yichang Hec Changjiang Pharm (5 min.)




Is Yichang Hec Changjiang Pharm growing?

Current yearPrevious yearGrowGrow %
How rich?$812.8m$802.3m$10.5m1.3%

How much money is Yichang Hec Changjiang Pharm making?

Current yearPrevious yearGrowGrow %
Making money$9.7m-$75m$84.8m867.1%
Net Profit Margin2.0%-64.3%--

How much money comes from the company's main activities?

3. Financial Health of Yichang Hec Changjiang Pharm (5 min.)




What can you expect buying and holding a share of Yichang Hec Changjiang Pharm? (5 min.)

Welcome investor! Yichang Hec Changjiang Pharm's management wants to use your money to grow the business. In return you get a share of Yichang Hec Changjiang Pharm.

What can you expect buying and holding a share of Yichang Hec Changjiang Pharm?

First you should know what it really means to hold a share of Yichang Hec Changjiang Pharm. And how you can make/lose money.

Speculation

The Price per Share of Yichang Hec Changjiang Pharm is HK$12.78. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Yichang Hec Changjiang Pharm.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Yichang Hec Changjiang Pharm, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$7.23. Based on the TTM, the Book Value Change Per Share is HK$0.09 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.87 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Yichang Hec Changjiang Pharm.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.010.1%0.010.1%-0.09-0.7%0.090.7%0.070.5%
Usd Book Value Change Per Share0.010.1%0.010.1%0.110.9%0.090.7%0.080.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.040.3%0.030.2%
Usd Total Gains Per Share0.010.1%0.010.1%0.110.9%0.131.0%0.110.9%
Usd Price Per Share0.83-0.83-0.78-2.34-1.91-
Price to Earnings Ratio74.67-74.67--9.13-24.11-23.33-
Price-to-Total Gains Ratio69.03-69.03-7.04-26.04-15.42-
Price to Book Ratio0.90-0.90-0.85-3.41-3.41-
Price-to-Total Gains Ratio69.03-69.03-7.04-26.04-15.42-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.632006
Number of shares612
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.04
Usd Book Value Change Per Share0.010.09
Usd Total Gains Per Share0.010.13
Gains per Quarter (612 shares)7.3679.54
Gains per Year (612 shares)29.44318.15
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10291995223308
205948190447626
308877284670944
401181063798931262
5014713547411171580
6017716456913401898
7020619366415632216
8023522275917872534
9026525185320102852
10029428094822333170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%9.01.01.081.8%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.02.00.080.0%9.02.00.081.8%
Dividend per Share0.00.01.00.0%1.00.02.033.3%3.00.02.060.0%8.00.02.080.0%8.00.03.072.7%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.02.00.080.0%9.02.00.081.8%

Fundamentals of Yichang Hec Changjiang Pharm

About Yichang Hec Changjiang Pharm

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, cardiovascular diseases, and anti-infection diseases in the People's Republic of China. It manufactures and sells active pharmaceutical ingredients; researches and develops pharmaceutical products, and medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Jointown Pharmaceutical Group Co., Ltd., as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. operates as a subsidiary of Sunshine Lake Pharma Co., Ltd.

Fundamental data was last updated by Penke on 2024-04-15 23:35:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Yichang Hec Changjiang Pharm.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Yichang Hec Changjiang Pharm earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Yichang Hec Changjiang Pharm to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 2.0% means that $0.02 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Yichang Hec Changjiang Pharm:

  • The MRQ is 2.0%. The company is making a profit. +1
  • The TTM is 2.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.0%TTM2.0%0.0%
TTM2.0%YOY-64.3%+66.4%
TTM2.0%5Y8.4%-6.3%
5Y8.4%10Y21.0%-12.6%
1.1.2. Return on Assets

Shows how efficient Yichang Hec Changjiang Pharm is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Yichang Hec Changjiang Pharm to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.6% Return on Assets means that Yichang Hec Changjiang Pharm generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Yichang Hec Changjiang Pharm:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.6%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.6%TTM0.6%0.0%
TTM0.6%YOY-5.2%+5.7%
TTM0.6%5Y8.1%-7.5%
5Y8.1%10Y9.5%-1.4%
1.1.3. Return on Equity

Shows how efficient Yichang Hec Changjiang Pharm is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Yichang Hec Changjiang Pharm to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.2% Return on Equity means Yichang Hec Changjiang Pharm generated $0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Yichang Hec Changjiang Pharm:

  • The MRQ is 1.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.2%TTM1.2%0.0%
TTM1.2%YOY-9.4%+10.6%
TTM1.2%5Y14.7%-13.5%
5Y14.7%10Y17.7%-3.0%

1.2. Operating Efficiency of Yichang Hec Changjiang Pharm.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Yichang Hec Changjiang Pharm is operating .

  • Measures how much profit Yichang Hec Changjiang Pharm makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Yichang Hec Changjiang Pharm to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Yichang Hec Changjiang Pharm:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-50.1%+50.1%
TTM-5Y10.2%-10.2%
5Y10.2%10Y26.4%-16.1%
1.2.2. Operating Ratio

Measures how efficient Yichang Hec Changjiang Pharm is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.93 means that the operating costs are $0.93 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Yichang Hec Changjiang Pharm:

  • The MRQ is 0.925. The company is less efficient in keeping operating costs low.
  • The TTM is 0.925. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.925TTM0.9250.000
TTM0.925YOY1.953-1.028
TTM0.9255Y1.003-0.078
5Y1.00310Y0.816+0.187

1.3. Liquidity of Yichang Hec Changjiang Pharm.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Yichang Hec Changjiang Pharm is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.01 means the company has $1.01 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Yichang Hec Changjiang Pharm:

  • The MRQ is 1.015. The company is just able to pay all its short-term debts.
  • The TTM is 1.015. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.015TTM1.0150.000
TTM1.015YOY1.662-0.647
TTM1.0155Y1.593-0.578
5Y1.59310Y2.677-1.084
1.3.2. Quick Ratio

Measures if Yichang Hec Changjiang Pharm is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Yichang Hec Changjiang Pharm to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.51 means the company can pay off $0.51 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Yichang Hec Changjiang Pharm:

  • The MRQ is 0.508. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.508. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.508TTM0.5080.000
TTM0.508YOY1.274-0.766
TTM0.5085Y1.318-0.810
5Y1.31810Y2.318-1.000

1.4. Solvency of Yichang Hec Changjiang Pharm.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Yichang Hec Changjiang Pharm assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Yichang Hec Changjiang Pharm to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.51 means that Yichang Hec Changjiang Pharm assets are financed with 50.5% credit (debt) and the remaining percentage (100% - 50.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Yichang Hec Changjiang Pharm:

  • The MRQ is 0.505. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.505. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.505TTM0.5050.000
TTM0.505YOY0.449+0.056
TTM0.5055Y0.429+0.076
5Y0.42910Y0.406+0.024
1.4.2. Debt to Equity Ratio

Measures if Yichang Hec Changjiang Pharm is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Yichang Hec Changjiang Pharm to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 102.0% means that company has $1.02 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Yichang Hec Changjiang Pharm:

  • The MRQ is 1.020. The company is able to pay all its debts with equity. +1
  • The TTM is 1.020. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.020TTM1.0200.000
TTM1.020YOY0.815+0.205
TTM1.0205Y0.841+0.180
5Y0.84110Y0.970-0.129

2. Market Valuation of Yichang Hec Changjiang Pharm

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Yichang Hec Changjiang Pharm generates.

  • Above 15 is considered overpriced but always compare Yichang Hec Changjiang Pharm to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 74.67 means the investor is paying $74.67 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Yichang Hec Changjiang Pharm:

  • The EOD is 146.809. Based on the earnings, the company is expensive. -2
  • The MRQ is 74.668. Based on the earnings, the company is expensive. -2
  • The TTM is 74.668. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD146.809MRQ74.668+72.141
MRQ74.668TTM74.6680.000
TTM74.668YOY-9.134+83.802
TTM74.6685Y24.105+50.563
5Y24.10510Y23.329+0.777
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Yichang Hec Changjiang Pharm:

  • The EOD is 12.277. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.244. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 6.244. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD12.277MRQ6.244+6.033
MRQ6.244TTM6.2440.000
TTM6.244YOY-3.995+10.239
TTM6.2445Y47.110-40.866
5Y47.11010Y6.573+40.537
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Yichang Hec Changjiang Pharm is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Yichang Hec Changjiang Pharm:

  • The EOD is 1.767. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.899. Based on the equity, the company is cheap. +2
  • The TTM is 0.899. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.767MRQ0.899+0.868
MRQ0.899TTM0.8990.000
TTM0.899YOY0.854+0.044
TTM0.8995Y3.406-2.508
5Y3.40610Y3.409-0.003
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Yichang Hec Changjiang Pharm compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0940.0940%0.866-89%0.714-87%0.654-86%
Book Value Per Share--7.2347.2340%7.140+1%6.124+18%4.181+73%
Current Ratio--1.0151.0150%1.662-39%1.593-36%2.677-62%
Debt To Asset Ratio--0.5050.5050%0.449+12%0.429+18%0.406+25%
Debt To Equity Ratio--1.0201.0200%0.815+25%0.841+21%0.970+5%
Dividend Per Share----0%-0%0.303-100%0.228-100%
Eps--0.0870.0870%-0.668+867%0.711-88%0.533-84%
Free Cash Flow Per Share--1.0411.0410%-1.527+247%-0.311+130%-0.096+109%
Free Cash Flow To Equity Per Share--0.0740.0740%-1.297+1863%-0.005+106%0.230-68%
Gross Profit Margin--1.0001.0000%1.0000%0.340+194%0.492+103%
Intrinsic Value_10Y_max--10.717--------
Intrinsic Value_10Y_min--1.984--------
Intrinsic Value_1Y_max---0.013--------
Intrinsic Value_1Y_min---0.263--------
Intrinsic Value_3Y_max--0.790--------
Intrinsic Value_3Y_min---0.395--------
Intrinsic Value_5Y_max--2.591--------
Intrinsic Value_5Y_min---0.093--------
Market Cap8355155040.000+32%5719790050.0005719790050.0000%5367802970.000+7%16434775001.200-65%13092829237.508-56%
Net Profit Margin--0.0200.0200%-0.643+3244%0.084-76%0.210-90%
Operating Margin----0%-0.5010%0.102-100%0.264-100%
Operating Ratio--0.9250.9250%1.953-53%1.003-8%0.816+13%
Pb Ratio1.767+49%0.8990.8990%0.854+5%3.406-74%3.409-74%
Pe Ratio146.809+49%74.66874.6680%-9.134+112%24.105+210%23.329+220%
Price Per Share12.780+49%6.5006.5000%6.100+7%18.356-65%14.961-57%
Price To Free Cash Flow Ratio12.277+49%6.2446.2440%-3.995+164%47.110-87%6.573-5%
Price To Total Gains Ratio135.720+49%69.02869.0280%7.043+880%26.041+165%15.416+348%
Quick Ratio--0.5080.5080%1.274-60%1.318-61%2.318-78%
Return On Assets--0.0060.0060%-0.052+965%0.081-93%0.095-94%
Return On Equity--0.0120.0120%-0.094+877%0.147-92%0.177-93%
Total Gains Per Share--0.0940.0940%0.866-89%1.018-91%0.882-89%
Usd Book Value--812897211.212812897211.2120%802315802.118+1%693397915.907+17%462971353.769+76%
Usd Book Value Change Per Share--0.0120.0120%0.111-89%0.091-87%0.083-86%
Usd Book Value Per Share--0.9240.9240%0.912+1%0.782+18%0.534+73%
Usd Dividend Per Share----0%-0%0.039-100%0.029-100%
Usd Eps--0.0110.0110%-0.085+867%0.091-88%0.068-84%
Usd Free Cash Flow--116977178.468116977178.4680%-171588095.599+247%-35171999.908+130%-9463456.556+108%
Usd Free Cash Flow Per Share--0.1330.1330%-0.195+247%-0.040+130%-0.012+109%
Usd Free Cash Flow To Equity Per Share--0.0090.0090%-0.166+1863%-0.001+106%0.029-68%
Usd Market Cap1066953298.608+32%730417189.385730417189.3850%685468439.269+7%2098720767.653-65%1671954293.630-56%
Usd Price Per Share1.632+49%0.8300.8300%0.779+7%2.344-65%1.911-57%
Usd Profit--9782203.1009782203.1000%-75042777.300+867%81463763.160-88%59715648.650-84%
Usd Revenue--478230370.400478230370.4000%116690727.600+310%402034155.620+19%252011697.590+90%
Usd Total Gains Per Share--0.0120.0120%0.111-89%0.130-91%0.113-89%
 EOD+4 -4MRQTTM+0 -0YOY+20 -125Y+15 -2110Y+12 -24

3.2. Fundamental Score

Let's check the fundamental score of Yichang Hec Changjiang Pharm based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15146.809
Price to Book Ratio (EOD)Between0-11.767
Net Profit Margin (MRQ)Greater than00.020
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.508
Current Ratio (MRQ)Greater than11.015
Debt to Asset Ratio (MRQ)Less than10.505
Debt to Equity Ratio (MRQ)Less than11.020
Return on Equity (MRQ)Greater than0.150.012
Return on Assets (MRQ)Greater than0.050.006
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Yichang Hec Changjiang Pharm based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5072.735
Ma 20Greater thanMa 5011.536
Ma 50Greater thanMa 10010.422
Ma 100Greater thanMa 2009.863
OpenGreater thanClose12.400
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets11,889,800
Total Liabilities6,004,916
Total Stockholder Equity5,884,884
 As reported
Total Liabilities 6,004,916
Total Stockholder Equity+ 5,884,884
Total Assets = 11,889,800

Assets

Total Assets11,889,800
Total Current Assets5,014,020
Long-term Assets6,875,780
Total Current Assets
Cash And Cash Equivalents 923,543
Short-term Investments 290,000
Net Receivables 1,005,817
Inventory 315,027
Other Current Assets 2,389,101
Total Current Assets  (as reported)5,014,020
Total Current Assets  (calculated)4,923,488
+/- 90,532
Long-term Assets
Property Plant Equipment 3,518,765
Intangible Assets 2,920,646
Other Assets 250,300
Long-term Assets  (as reported)6,875,780
Long-term Assets  (calculated)6,689,711
+/- 186,069

Liabilities & Shareholders' Equity

Total Current Liabilities4,940,781
Long-term Liabilities879,018
Total Stockholder Equity5,884,884
Total Current Liabilities
Short Long Term Debt 3,130,306
Accounts payable 167,387
Total Current Liabilities  (as reported)4,940,781
Total Current Liabilities  (calculated)3,297,693
+/- 1,643,088
Long-term Liabilities
Long term Debt Total 691,529
Long-term Liabilities  (as reported)879,018
Long-term Liabilities  (calculated)691,529
+/- 187,489
Total Stockholder Equity
Common Stock879,968
Retained Earnings 5,004,916
Total Stockholder Equity (as reported)5,884,884
Total Stockholder Equity (calculated)5,884,884
+/-0
Other
Capital Stock879,968
Cash And Equivalents923,543
Cash and Short Term Investments 1,213,543
Common Stock Shares Outstanding 879,968
Liabilities and Stockholders Equity 11,889,800
Net Debt 2,898,292
Net Invested Capital 9,706,719
Net Working Capital 73,239
Property Plant and Equipment Gross 4,091,810



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
1,490,787
1,658,116
949,531
2,577,415
2,831,109
3,775,975
4,560,940
9,912,339
9,561,267
10,541,581
11,889,800
11,889,80010,541,5819,561,2679,912,3394,560,9403,775,9752,831,1092,577,415949,5311,658,1161,490,787
   > Total Current Assets 
0
859,563
478,245
1,809,924
1,901,468
2,068,630
1,785,364
5,330,709
3,264,110
2,057,376
5,014,020
5,014,0202,057,3763,264,1105,330,7091,785,3642,068,6301,901,4681,809,924478,245859,5630
       Cash And Cash Equivalents 
31,236
32,367
86,554
1,353,651
1,212,072
887,183
593,746
2,779,138
2,044,967
1,131,121
923,543
923,5431,131,1212,044,9672,779,138593,746887,1831,212,0721,353,65186,55432,36731,236
       Short-term Investments 
25,000
0
25,000
33,000
238,988
346,519
0
0
0
0
290,000
290,0000000346,519238,98833,00025,000025,000
       Net Receivables 
429,313
595,167
162,857
250,094
331,611
735,257
995,619
2,344,951
599,757
445,634
1,005,817
1,005,817445,634599,7572,344,951995,619735,257331,611250,094162,857595,167429,313
       Other Current Assets 
5,971
6,707
3,558
41,077
2,635
11,704
31,713
0
221,191
99,768
2,389,101
2,389,10199,768221,191031,71311,7042,63541,0773,5586,7075,971
   > Long-term Assets 
0
0
0
0
929,641
1,707,345
2,775,576
4,581,630
6,297,157
8,484,205
6,875,780
6,875,7808,484,2056,297,1574,581,6302,775,5761,707,345929,6410000
       Property Plant Equipment 
706,838
770,987
463,635
467,099
495,682
670,225
1,351,479
2,025,507
2,835,706
3,216,555
3,518,765
3,518,7653,216,5552,835,7062,025,5071,351,479670,225495,682467,099463,635770,987706,838
       Goodwill 
0
0
0
0
0
75,896
75,896
75,896
75,896
75,896
0
075,89675,89675,89675,89675,89600000
       Intangible Assets 
0
0
85,631
83,699
81,767
374,170
498,604
828,295
2,709,591
3,271,990
2,920,646
2,920,6463,271,9902,709,591828,295498,604374,17081,76783,69985,63100
       Long-term Assets Other 
0
0
0
0
929,641
1,707,345
2,775,576
4,581,630
0
0
0
0004,581,6302,775,5761,707,345929,6410000
> Total Liabilities 
1,069,666
1,179,195
672,276
434,566
373,302
715,389
882,012
5,289,184
4,457,608
4,733,300
6,004,916
6,004,9164,733,3004,457,6085,289,184882,012715,389373,302434,566672,2761,179,1951,069,666
   > Total Current Liabilities 
640,678
755,260
445,990
271,166
284,281
640,747
812,798
2,311,649
4,161,213
1,238,064
4,940,781
4,940,7811,238,0644,161,2132,311,649812,798640,747284,281271,166445,990755,260640,678
       Short-term Debt 
0
1,008,044
270,000
105,000
70,000
10,000
53,399
132,660
2,820,804
0
0
002,820,804132,66053,39910,00070,000105,000270,0001,008,0440
       Short Long Term Debt 
0
1,008,044
270,000
105,000
70,000
10,000
53,399
132,660
2,820,804
48,477
3,130,306
3,130,30648,4772,820,804132,66053,39910,00070,000105,000270,0001,008,0440
       Accounts payable 
69,237
37,672
53,744
33,411
24,306
59,867
80,554
184,697
240,666
193,473
167,387
167,387193,473240,666184,69780,55459,86724,30633,41153,74437,67269,237
       Other Current Liabilities 
65,666
47,814
71,466
104,001
154,887
445,723
561,049
1,664,309
313,064
515,775
0
0515,775313,0641,664,309561,049445,723154,887104,00171,46647,81465,666
   > Long-term Liabilities 
0
0
0
0
89,021
74,642
69,214
2,977,535
296,395
3,282,755
879,018
879,0183,282,755296,3952,977,53569,21474,64289,0210000
       Long term Debt Total 
0
0
0
90,000
20,000
10,000
0
2,902,600
189,853
3,145,025
691,529
691,5293,145,025189,8532,902,600010,00020,00090,000000
       Deferred Long Term Liability 
0
0
0
0
0
57,157
129,471
294,248
1,173,161
1,201,346
0
01,201,3461,173,161294,248129,47157,15700000
> Total Stockholder Equity
421,121
478,921
277,255
2,142,849
2,457,807
2,807,836
3,433,956
4,408,555
4,891,103
5,808,281
5,884,884
5,884,8845,808,2814,891,1034,408,5553,433,9562,807,8362,457,8072,142,849277,255478,921421,121
   Common Stock
170,800
170,800
170,800
450,659
450,823
452,023
452,023
448,820
879,968
879,968
879,968
879,968879,968879,968448,820452,023452,023450,823450,659170,800170,800170,800
   Retained Earnings 
242,257
300,057
98,391
1,692,190
548,550
879,235
1,505,355
2,726,072
2,905,553
2,317,904
5,004,916
5,004,9162,317,9042,905,5532,726,0721,505,355879,235548,5501,692,19098,391300,057242,257
   Capital Surplus 00000000000
   Treasury Stock000-142,2090000000
   Other Stockholders Equity 
0
8,064
8,064
1,456,614
1,458,434
1,476,578
1,476,578
1,375,872
1,105,582
2,610,409
0
02,610,4091,105,5821,375,8721,476,5781,476,5781,458,4341,456,6148,0648,0640



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in HKD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue3,744,952
Cost of Revenue-898,878
Gross Profit2,846,0742,846,074
 
Operating Income (+$)
Gross Profit2,846,074
Operating Expense-2,566,829
Operating Income321,068279,245
 
Operating Expense (+$)
Research Development129,614
Selling General Administrative1,551,047
Selling And Marketing Expenses-
Operating Expense2,566,8291,680,661
 
Net Interest Income (+$)
Interest Income281,646
Interest Expense-571,563
Other Finance Cost-15,010
Net Interest Income-274,907
 
Pretax Income (+$)
Operating Income321,068
Net Interest Income-274,907
Other Non-Operating Income Expenses-
Income Before Tax (EBT)39,422321,068
EBIT - interestExpense = -571,563
76,603
648,166
Interest Expense571,563
Earnings Before Interest and Taxes (EBIT)-610,985
Earnings Before Interest and Taxes (EBITDA)698,425
 
After tax Income (+$)
Income Before Tax39,422
Tax Provision--9,817
Net Income From Continuing Ops49,23949,239
Net Income76,603
Net Income Applicable To Common Shares76,603
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-274,907
 

Technical Analysis of Yichang Hec Changjiang Pharm
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Yichang Hec Changjiang Pharm. The general trend of Yichang Hec Changjiang Pharm is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Yichang Hec Changjiang Pharm's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Yichang Hec Changjiang Pharm.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 11.98 > 11.30 > 10.06.

Tweet this
Yichang Hec Changjiang Pharm Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Yichang Hec Changjiang Pharm. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Yichang Hec Changjiang Pharm Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Yichang Hec Changjiang Pharm. The current macd is 0.65161116.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Yichang Hec Changjiang Pharm price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Yichang Hec Changjiang Pharm. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Yichang Hec Changjiang Pharm price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Yichang Hec Changjiang Pharm Daily Moving Average Convergence/Divergence (MACD) ChartYichang Hec Changjiang Pharm Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Yichang Hec Changjiang Pharm. The current adx is 23.42.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Yichang Hec Changjiang Pharm shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Yichang Hec Changjiang Pharm Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Yichang Hec Changjiang Pharm. The current sar is 10.81.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Yichang Hec Changjiang Pharm Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Yichang Hec Changjiang Pharm. The current rsi is 72.74. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Yichang Hec Changjiang Pharm Daily Relative Strength Index (RSI) ChartYichang Hec Changjiang Pharm Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Yichang Hec Changjiang Pharm. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Yichang Hec Changjiang Pharm price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Yichang Hec Changjiang Pharm Daily Stochastic Oscillator ChartYichang Hec Changjiang Pharm Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Yichang Hec Changjiang Pharm. The current cci is 113.11.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Yichang Hec Changjiang Pharm Daily Commodity Channel Index (CCI) ChartYichang Hec Changjiang Pharm Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Yichang Hec Changjiang Pharm. The current cmo is 54.81.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Yichang Hec Changjiang Pharm Daily Chande Momentum Oscillator (CMO) ChartYichang Hec Changjiang Pharm Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Yichang Hec Changjiang Pharm. The current willr is -8.72483221.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Yichang Hec Changjiang Pharm Daily Williams %R ChartYichang Hec Changjiang Pharm Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Yichang Hec Changjiang Pharm.

Yichang Hec Changjiang Pharm Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Yichang Hec Changjiang Pharm. The current atr is 0.46430452.

Yichang Hec Changjiang Pharm Daily Average True Range (ATR) ChartYichang Hec Changjiang Pharm Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Yichang Hec Changjiang Pharm. The current obv is 235,598,924.

Yichang Hec Changjiang Pharm Daily On-Balance Volume (OBV) ChartYichang Hec Changjiang Pharm Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Yichang Hec Changjiang Pharm. The current mfi is 82.62.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Yichang Hec Changjiang Pharm Daily Money Flow Index (MFI) ChartYichang Hec Changjiang Pharm Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Yichang Hec Changjiang Pharm.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

Yichang Hec Changjiang Pharm Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Yichang Hec Changjiang Pharm based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5072.735
Ma 20Greater thanMa 5011.536
Ma 50Greater thanMa 10010.422
Ma 100Greater thanMa 2009.863
OpenGreater thanClose12.400
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Yichang Hec Changjiang Pharm with someone you think should read this too:
  • Are you bullish or bearish on Yichang Hec Changjiang Pharm? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Yichang Hec Changjiang Pharm? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Yichang Hec Changjiang Pharm

I send you an email if I find something interesting about Yichang Hec Changjiang Pharm.


Comments

How you think about this?

Leave a comment

Stay informed about Yichang Hec Changjiang Pharm.

Receive notifications about Yichang Hec Changjiang Pharm in your mailbox!